Vivos Therapeutics Stock Forecast

Sell candidate since Jul 16, 2026 Loss -4.77%

The Vivos Therapeutics, Inc. stock price gained 0.640% on the last trading day (Friday, 24th Jul 2026), rising from $0.391 to $0.393. During the last trading day the stock fluctuated 12.73% from a day low at $0.364 to a day high of $0.410. The price has fallen in 6 of the last 10 days and is down by -9% for this period. Volume fell on the last day by -133 thousand shares and in total, 153 thousand shares were bought and sold for approximately $59.99 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -38.95% during the next 3 months and, with a 90% probability hold a price between $0.178 and $0.398 at the end of this 3-month period.

VVOS Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, July 23, 2026, and so far it has risen 0.640%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Vivos Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.407 and $0.503. A break-up above any of these levels will issue buy signals. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Vivos Therapeutics, Inc. stock

Vivos Therapeutics, Inc. finds support from accumulated volume at $0.391 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0463 between high and low, or 12.73%. For the last week the stock has had daily average volatility of 6.50%.

Vivos Therapeutics, Inc. is oversold on RSI14 (14). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (VVOS) For The Upcoming Trading Day Of Monday 27th

For the upcoming trading day on Monday, 27th we expect Vivos Therapeutics, Inc. to open at $0.389, and during the day (based on 14 day Average True Range), to move between $0.369 and $0.417, which gives a possible trading interval of +/-$0.0480 (+/-13.00%) up or down from last closing price. If Vivos Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 13.00% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.391 (0.64%) than the resistance at $0.402 (2.31%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Vivos Therapeutics, Inc. stock A Buy?

Vivos Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -3.732 Sell Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 27, 2026 - $0.389 ( 1.06%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk